Literature DB >> 18500492

Levodopa reduces risk factors for vascular disease in parkinsonian patients.

Giulio Scigliano, Gabriele Ronchetti, Floriano Girotti, Massimo Musicco.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18500492     DOI： 10.1007/s00415-008-0869-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  14 in total

1.  Insulin resistance in type 1 (insulin-dependent) diabetes following hypoglycaemia--evidence for the importance of beta-adrenergic stimulation.

Authors:  S Attvall; J Fowelin; H von Schenck; I Lager; U Smith
Journal:  Diabetologia       Date:  1987-09       Impact factor: 10.122

2.  Elevated plasma levels of homocysteine in Parkinson's disease.

Authors:  W Kuhn; R Roebroek; H Blom; D van Oppenraaij; H Przuntek; A Kretschmer; T Büttner; D Woitalla; T Müller
Journal:  Eur Neurol       Date:  1998-11       Impact factor: 1.710

3.  Effect of L-dopa alone and in combination with an extracerebral decarboxylase inhibitor on blood pressure and some cardiovascular reflexes.

Authors:  A M Watanabe; T N Chase; P V Cardon
Journal:  Clin Pharmacol Ther       Date:  1970 Sep-Oct       Impact factor: 6.875

4.  Attenuation of postganglionic sympathetic nerve activity by L-dopa.

Authors:  T L Whitsett; P V Halushka; L I Goldberg
Journal:  Circ Res       Date:  1970-10       Impact factor: 17.367

5.  Dopamine receptors: applications in clinical cardiology.

Authors:  L I Goldberg; S I Rajfer
Journal:  Circulation       Date:  1985-08       Impact factor: 29.690

6.  Parkinsonism: onset, progression and mortality.

Authors:  M M Hoehn; M D Yahr
Journal:  Neurology       Date:  1967-05       Impact factor: 9.910

Review 7.  Dopamine: a role in the pathogenesis and treatment of hypertension.

Authors:  M B Murphy
Journal:  J Hum Hypertens       Date:  2000-04       Impact factor: 3.012

8.  Pharmacodynamics of benserazide assessed by its effects on endogenous and exogenous levodopa pharmacokinetics.

Authors:  J Dingemanse; C H Kleinbloesem; G Zürcher; N D Wood; C Crevoisier
Journal:  Br J Clin Pharmacol       Date:  1997-07       Impact factor: 4.335

Review 9.  Catecholamines: role in health and disease.

Authors:  R Laverty
Journal:  Drugs       Date:  1978-11       Impact factor: 9.546

Review 10.  Diagnostic criteria for Parkinson disease.

Authors:  D J Gelb; E Oliver; S Gilman
Journal:  Arch Neurol       Date:  1999-01
View more
  1 in total

Review 1.  Autonomic nervous system and risk factors for vascular disease. Effects of autonomic unbalance in schizophrenia and Parkinson's disease.

Authors:  Giulio Scigliano; Gabriele Ronchetti; Floriano Girotti
Journal:  Neurol Sci       Date:  2008-04-01       Impact factor: 3.307
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.